|Number of pages||2|
|Journal||Annals of Oncology|
|Publication status||Published - Dec 2019|
|Event||Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO) - Geneva, Switzerland|
Duration: 11 Dec 2019 → 14 Dec 2019
Gao, B., Goh, J., Markman, B., Voskoboynik, M., Gan, H. K., Coward, J., ... Millward, M. (2019). Safety and antitumor activity of sitravatinib in combination with tislelizumab in patients with advanced solid tumors: Ovarian cancer cohort data. Annals of Oncology, 30.